监管与产业动态· FierceBiotech·· 2 天前评分39
MimiVax’s cancer vaccine fails phase 2 glioblastoma study, but CEO still sees data as ‘inspiring’ - Fierce Biotech
MimiVax’s cancer vaccine fails phase 2 glioblastoma study, but CEO still sees data as ‘inspiring’ - Fierce Biotech
来源:监管与产业动态 · news.google.com